VX-670 Solution for Injection/Infusion, 0.9% saline solution (w/v)
VX23-670-001
Phase 2 small_molecule active
Quick answer
VX-670 Solution for Injection/Infusion, 0.9% saline solution (w/v) for Myotonic Dystrophy is a Phase 2 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Myotonic Dystrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active